NASDAQ:ONTX
Onconova Therapeutics Stock News
$1.00
+0 (+0%)
At Close: May 03, 2024
Onconova Therapeutics Announces Compliance with Nasdaq Bid Price Requirement
12:00pm, Tuesday, 04'th Aug 2020
NEWTOWN, Pa., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat canc
Onconova (ONTX) to Report Q2 Earnings: What's in the Offing?
03:52pm, Monday, 03'rd Aug 2020
Investors will focus on pipeline updates when Onconova (ONTX) reports Q2 results.
Bristol Myers Squibb NDA, And Other News: The Good, Bad And Ugly Of Biopharma
03:52pm, Thursday, 30'th Jul 2020
Bristol Myers Squibb resubmits multiple myeloma therapy application. Onconova reports progress of INSPIRE trial data analysis.
Topline INSPIRE Results are Expected by the End of the Third Quarter of 2020NEWTOWN, Pa., July 29, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutica
Onconova And The Conflict Lurking Beneath The Hype
10:14am, Wednesday, 29'th Jul 2020
Onconova has a pivotal readout in a Phase 3 trial for Rigosertib (named INSPIRE) in Myelodysplastic Syndrome due to read out in 2H2020.
Onconova Therapeutics Submits Application for Rigosertib to Participate in Federally Funded Human Studies in COVID-19 Disease
12:00pm, Monday, 27'th Jul 2020
Preclinical experiments with rigosertib in cellular models demonstrate marked inhibition of SARS-CoV-2 replicationNEWTOWN, Pa., July 27, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: O
NEWTOWN, Pa., July 23, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat canc
Onconova Therapeutics, Inc. (ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (
Dyadic International (DYAI) Receives a Buy from Noble Financial - Markets
08:06pm, Monday, 29'th Jun 2020
Noble Financial analyst Ahu Demir reiterated a Buy rating on Dyadic International (DYAI – Research Report) today and set a
Onconova Initiates Phase I/IIa Study on Lung Cancer Candidate
02:43pm, Tuesday, 23'rd Jun 2020
Onconova (ONTX) starts investigator-initiated phase I/IIa study of oral rigosertib plus Bristol-Myers Squibb's Opdivo in advanced metastatic KRAS-mutated lung adenocarcinoma.
Analysts Are Bullish on These Healthcare Stocks: Mersana Therapeutics (MRSN), Onconova Therapeutics (ONTX) - Markets
01:56pm, Tuesday, 23'rd Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mersana Therapeutics
Onconova Therapeutics Announces Participation in Noble Capital Markets Investor Webinar
12:00pm, Tuesday, 23'rd Jun 2020
NEWTOWN, Pa., June 23, 2020 -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to.
Onconova Therapeutics, Inc. (ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (
Noble Financial Thinks Onconova Therapeutics' Stock is Going to Recover - Markets
11:56am, Monday, 15'th Jun 2020
In a report released today, Ahu Demir from Noble Financial reiterated a Buy rating on Onconova Therapeutics (ONTX – Research
H.C. Wainwright Thinks Onconova Therapeutics' Stock is Going to Recover - Markets
10:18am, Monday, 15'th Jun 2020
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Onconova Therapeutics (ONTX – Research
